Myocardial phosphoproteomics and single cardiomyocyte force measurements endorse DYRK1A as a candidate therapeutic target for incomplete reverse remodelling after aortic valve replacement
20 May 2023 (13:00 - 15:00)
Organised by: 
Abstract
Slides
About the speaker
Faculty of Medicine University of Porto, Porto (Portugal)
2 More presentations in this session
Doctor L. Meems (Groningen, NL)
Doctor Y. Taverne (Rotterdam, NL)
Access the full session
The Event
Heart Failure 2023
20 May 2023
13:00 CET
You may be interested in
/f/125658/640x360/fe5123d923/ett-s3-ep15.png)
Congress Session
Congress Session
